Proton pump inhibitor and histamine-2 receptor antagonist use and risk of liver cancer in two population-based studies.

Kim Tu Tran Úna C Mc MenaminB HicksP MurchieA P ThriftH G ColemanL IversenB T JohnstonA J LeeC R Cardwell

Published in: Alimentary pharmacology & therapeutics (2018)

We found some evidence that PPI use was associated with liver cancer. Whether this association is causal or reflects residual confounding or reverse causation requires additional research.

Keyphrases

case control
protein protein
electron transfer